Mercer Global Advisors
PALI icon

Mercer Global Advisors’s Palisade Bio PALI Stock Holding History

Mercer Global Advisors’s Portfolio PALI Stock Details PALI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$31 Buy
+15
New +$30 ﹤0.01% 6028

Other funds holding PALI

SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
BC
BIT Capital Berlin, Germany $3.38B AUM 214.12% 1-Year Est. Return
SAM
Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return
LCM
Landscape Capital Management Englewood, New Jersey $1.54B AUM 30.95% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Mercer Global Advisors's PALI Position: Q2 2026 in Review

Mercer Global Advisors opened a new position in Palisade Bio (PALI) in Q2 2026: 15 shares worth $31. The stake represents ﹤0.01% of the portfolio and ranks #6028 among its holdings.

47 funds tracked by Wall St. Rank hold PALI as of Q2 2026.

  • Mercer Global Advisors held 15 shares of Palisade Bio worth $31 as of Q2 2026.
  • Palisade Bio was a new Mercer Global Advisors position in Q2 2026.
  • Palisade Bio made up ﹤0.01% of Mercer Global Advisors's portfolio in Q2 2026, its #6028 holding.
  • 47 funds tracked by Wall St. Rank held Palisade Bio as of Q2 2026.

Based on Mercer Global Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.